Biomaterial scaffolds recruit an aggressive population of metastatic tumor cells in vivo

For most cancers, metastasis is the point at which clinical treatment shifts from curative intent to extending survival. Biomaterial implants acting as a synthetic pre-metastatic niche recruit metastatic cancer cells and provide a survival advantage, and their use as a diagnostic platform requires assessing their relevance to disease progression. Here we showed that scaffold-captured tumor cells (SCAF) were 30 times more metastatic to the lung than primary tumor cells (PT), similar to cells derived from lung micrometastases (LUNG). SCAF cells were more aggressive in vitro, demonstrated higher levels of migration, invasion, and mammosphere formation, and had a greater proportion of cancer stem cells than PT. SCAF were highly enriched for gene expression signatures associated with metastasis and had associated genomic structural changes including globally enhanced entropy. Collectively, our findings demonstrate that SCAF cells are distinct from PT and more closely resemble LUNG, indicating that tumor cells retrieved from scaffolds are reflective of cells at metastatic sites.

https://ift.tt/2GNsD1s